meta_pixel
Tapesearch Logo
Log in
Post Reports

Inside Silicon Valley’s push to breed super-babies

Post Reports

The Washington Post

Daily News, Politics, News

4.45.1K Ratings

🗓️ 14 October 2025

⏱️ 25 minutes

🧾️ Download transcript

Summary

A crop of Silicon Valley startups offers the hope of eradicating disease by testing embryos for genetic abnormalities and the potential for future illness. But those tests come with a high price tag and ethical questions about the use of predictive technology to decide who gets born – or not.

Host Elahe Ezadi speaks with Silicon Valley correspondent Elizabeth Dwoskin about the cutting-edge science driving fertility startups, what families who use them say, and how this trend fits into Silicon Valley’s obsession with hacking our health.

Today’s show was produced by Laura Benshoff and Arjun Singh. It was edited by Ariel Plotnick and mixed by Sam Bair. 

Subscribe to The Washington Post here.

Transcript

Click on a timestamp to play from that location

0:00.0

America is changing. And so is the world.

0:04.4

But what's happening in America isn't just the cause of global upheaval.

0:08.6

It's also a symptom of disruption that's happening everywhere.

0:12.4

I'm Asma Khalid in Washington, D.C.

0:14.6

I'm Tristan Redman in London, and this is the global story.

0:18.8

Every weekday will bring you a story from this intersection, where the world and America meet.

0:24.4

Listen on BBC.com or wherever you get your podcasts.

0:31.7

Silicon Valley is on a quest to optimize babies.

0:36.5

This is baby Jaffe. Oh, my goodness. So what has the first couple of months been babies. This is baby Jaffe?

0:38.0

Oh, my goodness.

0:39.1

So what is the first couple of months been like?

0:40.9

This is from a promotional video for a company called Orchid Health.

0:45.6

It offers advanced genetic testing for embryos.

0:49.7

In the video, Mom Leah leans over a baby in a bouncy chair.

0:55.0

Leah describes how Orchid helped her and her husband create baby Jaffe.

1:00.0

They tested their embryos, talked to a genetic counselor.

1:05.0

We actually talked with one of the genetic counselors with Orchid.

1:08.0

We went online and looked at all the results and then selected an embryo

1:11.7

for implantation. So as you would, you want an embryo. But for us, the embryo test.

1:17.8

Lizzie Dwaskin is the post-Silicon Valley correspondent. She's been reporting on startups, like Orchid,

1:24.9

that are getting into the fertility game. Orchid Health is a company here in San Francisco that's part of this growing crop of

1:31.3

startups that are offering what I would call a brave new world of genetic predictions.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Washington Post, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Washington Post and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.